Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2969886 | The Journal of Heart and Lung Transplantation | 2016 | 8 Pages |
Abstract
HCV-positive status is a rare problem when considering both lung recipients and donors. Current data demonstrate significantly worse outcomes for HCV-negative patients receiving an HCV+ lung; however, since 2000, HCV+ recipients undergoing lung transplantation appear to have survival approximating that of HCVâ recipients, an improvement from previous years. Recent medical advances in treatment for HCV may further improve outcomes in these groups.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Brian R. MD, Asvin M. MD, Paul J. MD, Brian C. MD, Laurie D. MD, MHS, R. MD, Matthew G. MD,